Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous PAP-loaded Dendritic Cell Vaccine (Sipuleucel-T, APC8015, Provenge®) in Patients With Non-metastatic Prostate Cancer Who Experience PSA Elevation Following Radical Prostatectomy: a Randomized, Controlled, Double-blind Trial

NCT00779402 is registered in ClinicalTrials.gov with Dendreon as lead sponsor.

NCT NCT00779402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00779402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous PAP-loaded Dendritic Cell Vaccine (Sipuleucel-T, APC8015, Provenge®) in Patients With Non-metastatic Prostate Cancer Who Experience PSA Elevation Following Radical Prostatectomy: a Randomized, Controlled, Double-blind Trial
Lead sponsor
Dendreon
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2001
Completion date
May 31, 2015
Enrollment
176 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer